This trial is testing a new cancer vaccine made from a person's own dendritic cells. Dendritic cells are powerful immune cells that help the body fight infections. The vaccine will be given with laboratory made agents GM-CSF and imiquimod. Researchers want to see if the vaccine is safe and if it has any effect on the person's cancer.
- Ovarian Cancer
- Primary Peritoneal Cancer
1 Primary · 3 Secondary · Reporting Duration: 2 years
Awards & Highlights
2 Treatment Groups
1 of 2
1 of 2
23 Total Participants · 2 Treatment Groups
Primary Treatment: Dendritic Cell/Tumor Fusion Vaccine · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · Female Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many individuals are currently partaking in this medical research?
"No longer seeking participants, this research was first posted on August 1st 2008 and last edited on January 25th 2022. If you are exploring other medical studies, presently there 694 active trials accepting patients with fallopian tubes cancer and 21 clinical investigations looking for volunteers to receive a Dendritic Cell/Tumor Fusion Vaccine." - Anonymous Online Contributor
What potential risks do patients face when utilizing Dendritic Cell/Tumor Fusion Vaccine?
"We have assigned Dendritic Cell/Tumor Fusion Vaccine a score of 2, as the available evidence suggests it is safe but efficacy data has yet to be produced." - Anonymous Online Contributor
Have any other investigations explored the efficacy of Dendritic Cell/Tumor Fusion Vaccine?
"Presently, 21 clinical trials for Dendritic Cell/Tumor Fusion Vaccine are taking place. 5 of these investigations have progressed to the Phase 3 stage. Locations offering this therapy span 84 different sites, with most being located in Houston, Texas." - Anonymous Online Contributor
What maladies can be remedied with the Dendritic Cell/Tumor Fusion Vaccine?
"Dendritic Cell/Tumor Fusion Vaccine is effective at treating scalp structure, condylomata acuminata, and facial lesions." - Anonymous Online Contributor
Is it possible for new participants to join this clinical trial?
"This medical trial is no longer accepting new participants. It was first posted on August 1st, 2008 and the most recent update to its information occurred on January 25th, 2022. If searching for other studies, 694 clinical trials are actively looking for patients with fallopian tubes cancer while 21 of them seek persons interested in joining a Dendritic Cell/Tumor Fusion Vaccine study." - Anonymous Online Contributor